Details for New Drug Application (NDA): 021746
✉ Email this page to a colleague
The generic ingredient in SURFAXIN is lucinactant. Additional details are available on the lucinactant profile page.
Summary for 021746
| Tradename: | SURFAXIN |
| Applicant: | Lees Pharm Hk |
| Ingredient: | lucinactant |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;INTRATRACHEAL | Strength | 8.5ML | ||||
| Approval Date: | Mar 6, 2012 | TE: | RLD: | No | |||||
Expired US Patents for NDA 021746
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lees Pharm Hk | SURFAXIN | lucinactant | SUSPENSION;INTRATRACHEAL | 021746-001 | Mar 6, 2012 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
